Literature DB >> 11516570

Noradrenergic modulation of human cortex excitability by the presynaptic alpha(2)-antagonist yohimbine.

C Plewnia1, M Bartels, L Cohen, C Gerloff.   

Abstract

The objective of this study was to determine if yohimbine, a central norepinephrine enhancing drug, increases cortico-motoneuronal excitability in intact humans. Transcranial magnetic stimulation was used to assess excitability of the motor system reflected in the parameters motor threshold, recruitment curve, intracortical inhibition and intracortical facilitation before and after oral administration of 20 and 40 mg yohimbine. Oral intake of 40 but not 20 mg yohimbine increased slope and plateau of the recruitment curve and intracortical facilitation. Motor threshold and intracortical inhibition remained unchanged. The data show that pharmacological enhancement of central norepinephrine in humans is effective to increase the cortico-motoneuronal excitability. Since cortical excitability is closely linked to neuroplasticity, this observation might be of possible relevance for strategies to enhance rehabilitative processes after cortical lesions by pairing noradrenergic drugs with motor training.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11516570     DOI: 10.1016/s0304-3940(01)01921-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

Review 1.  Modulation of motor cortex excitability by sustained peripheral stimulation: the interaction between the motor cortex and the cerebellum.

Authors:  Andreas R Luft; Mario-Ubaldo Manto; Nordeyn Oulad Ben Taib
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

2.  No effects of enhanced central norepinephrine on finger-sequence learning and attention.

Authors:  Christian Plewnia; Julia Hoppe; Christian Gerloff
Journal:  Psychopharmacology (Berl)       Date:  2006-06-10       Impact factor: 4.530

Review 3.  Revisiting the excitation/inhibition imbalance hypothesis of ASD through a clinical lens.

Authors:  Russell G Port; Lindsay M Oberman; Timothy Pl Roberts
Journal:  Br J Radiol       Date:  2019-06-11       Impact factor: 3.039

4.  Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression.

Authors:  A Münchau; J M Langosch; W Gerschlager; J C Rothwell; M Orth; M R Trimble
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

Review 5.  Neurochemical changes underpinning the development of adjunct therapies in recovery after stroke: A role for GABA?

Authors:  Ainslie Johnstone; Jacob M Levenstein; Emily L Hinson; Charlotte J Stagg
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-20       Impact factor: 6.200

Review 6.  Transcranial magnetic stimulation in autism spectrum disorder: Challenges, promise, and roadmap for future research.

Authors:  Lindsay M Oberman; Peter G Enticott; Manuel F Casanova; Alexander Rotenberg; Alvaro Pascual-Leone; James T McCracken
Journal:  Autism Res       Date:  2015-11-04       Impact factor: 5.216

7.  Treatment pulse application for magnetic stimulation.

Authors:  Sun-Seob Choi; Whi-Young Kim
Journal:  J Biomed Biotechnol       Date:  2011-06-12

8.  Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder.

Authors:  Aimee M Hunter; Michael J Minzenberg; Ian A Cook; David E Krantz; Jennifer G Levitt; Natalie M Rotstein; Shweta A Chawla; Andrew F Leuchter
Journal:  Brain Behav       Date:  2019-04-02       Impact factor: 2.708

9.  Acute and Chronic Noradrenergic Effects on Cortical Excitability in Healthy Humans.

Authors:  Hsiao-I Kuo; Walter Paulus; Giorgi Batsikadze; Asif Jamil; Min-Fang Kuo; Michael A Nitsche
Journal:  Int J Neuropsychopharmacol       Date:  2017-08-01       Impact factor: 5.176

Review 10.  Cortical Circuit Dysfunction as a Potential Driver of Amyotrophic Lateral Sclerosis.

Authors:  Aurore Brunet; Geoffrey Stuart-Lopez; Thibaut Burg; Jelena Scekic-Zahirovic; Caroline Rouaux
Journal:  Front Neurosci       Date:  2020-04-29       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.